Putting evidence into practice®: Evidence-based interventions for the management of oral mucositis

Clinical Journal of Oncology Nursing

Volumn 12, Issue 1, 2008, Pages 142-152

  Harris, Debra J ^a   Eilers, June ^b   Harriman, Amber ^a   Cashavelly, Barbara J ^c   Maxwell, Cathy ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^d Advanced Medical Specialties   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

CRYOTHERAPY; EVIDENCE BASED MEDICINE; HEALTH CARE PLANNING; HUMAN; METHODOLOGY; MOUTH HYGIENE; NEOPLASM; NURSE ATTITUDE; NURSING; NURSING ASSESSMENT; NURSING EVALUATION RESEARCH; ONCOLOGY NURSING; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REVIEW; STOMATITIS;

ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CRYOTHERAPY; EVIDENCE-BASED MEDICINE; HEALTH PLANNING GUIDELINES; HUMANS; NEOPLASMS; NURSE'S ROLE; NURSING ASSESSMENT; NURSING EVALUATION RESEARCH; ONCOLOGIC NURSING; ORAL HYGIENE; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; STOMATITIS;

EID: 42949159870     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/08.CJON.142-152     Document Type: Article

References (45)

1. Rubenstein, E.B., Peterson, D.E., Schubert, M., Keefe, D., McGuire, D., Epstein, J., et al. (2004). Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer, 100(9, Suppl.), 2026-2046.
2. McGuire, D., Correa, M., Johnson, J., & Wienandts, P. (2006). The role of basic oral care and good clinical practice principles in the management of oral mucositis. Supportive Care in Cancer, 14, 541-547.
3. Cheng, K.K., Molassiotis, A., Chang, A.M., Wai, W.C, & Cheung, S.S. (2001). Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in pediatric cancer patients. European Journal of Cancer, 37, 2056-2063.
4. Cheng, K.K., Chang, A.M., & Yuen, M.P. (2004). Prevention of oral mucositis in pediatric patients treated with chemotherapy: A randomized crossover trial comparing two protocols of oral care. European Journal of Cancer, 40, 1208-1216.
5. Dodd, M.J., Dibble, S.L., Miaskowski, C, MacPhail, L, Greenspan, D., Paul, S.M., et al. (2000). Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics, 90,39-47.
6. Multinational Association of Supportive Care in Cancer. (2005). Summary of evidence-based clinical practice guidelines for care of patients with oral and gastrointestinal mucositis (2005 update). Retrieved July 10, 2006, from http:// www.mascc.org/media/Resource_centers/Guidelines_mucositis.doc
7. Shih, A., Miaskowski, C, Dodd, M.J., Stotts, N.A., & MacPhail, L. (2002). A research review of the current treatments for radiation-induced oral mucositis in patients with head and neck cancer. Oncology Nursing Forum, 29, 1063-1078.
8. Kwong, K.K. (2004). Prevention and treatment of oropharyngeal mucositis following cancer therapy: Are there new approaches? Cancer Nursing, 27, 183-205.
9. Karagozoglu, S., & Filiz Ulusoy, M.F. (2005). Chemotherapy: The effect of oral cryotherapy on the development of mucositis. Journal of Clinical Nursing, 14, 754-765.
10. Lilleby, K., Garcia, P., Gooley T., McDonnnell, P.,Taber R., Holmberg, L, et al. (2006). A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation, 37, 1031-1035.
11. Mori, T, Yamazaki, R., Aisa, Y, Nakazato, T, Kudo, M., Yashima, T, et al. (2006). Brief oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Supportive Care in Cancer, 14,392-395.
12. Nikoletti, S., Hyde, S., Shaw, T, Myers, H., & Kristjanson, L.J. (2005). Comparison of plain ice and favoured ice for preventing oral mucositis associated with the use of 5-fuorouracil. Journal of Clinical Nursing, 14, 750-753.
13. Tartarone, A., Matera, R., Romano, G., Vigliotti, M.L, & Di Renzo, N. (2005). Prevention of high-dose melphalan-induced mucositis by cryotherapy. Leukemia and Lymphoma, 46, 633-634.
14. Dumontet, C, Sonnet, A., Bastion, Y, Salles, G., Espinouse, D, & Coiffer, B. (1994). Prevention of high dose L-PAM-induced mucositis by cryotherapy. Bone Marrow Transplantation, 14,492-494.
15. Migliorati, C.A., Oberle-Edwards, L, & Schubert, M. (2006). The role of alternative and natural agents, cryotherapy and/or laser for management of alimentary mucositis. Supportive Care in Cancer, 14, 533-540.
16. Scully, C, Sonis, S., & Diz, P.D. (2006). Oral mucositis. Oral Diseases, 12, 229-241.
17. Spielberger, R., Stiff, P., Bensinger, W., Gentile, T. Weisdorf, D, Kewalramani, T, et al. (2004). Palifermin for oral mucositis after intensive therapy for hematologic cancers. New England Journal of Medicine, 351, 2590-2598.
18. von Bultzingslowen, I., Brennan, M.T., Spijkervet, F.K., Logan, R., Stringer, A., Raber-Durlacher, J.E., et al. (2006). Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis. Supportive Care in Cancer, 14, 519-527.
19. Brizel, D.M., & Overgaard, J. (2003). Does amifostine have a role in chemora-diation treatment? Lancet Oncology, 4, 378-381.
20. Bensadoun, R.J., Schubert, M.M., Lalla, R.V., & Keefe, D. (2006). Amifostine in the management of radiation-induced and chemo-induced mucositis. Supportive Care in Cancer, 14, 566-572.
21. Eilers, J. (2004). Nursing interventions and supportive care for the prevention and treatment of oral mucositis associated with cancer treatment. Oncology Nursing Forum, 31(4, Suppl.), 13-23.
22. Antonadou, D., Throuvalas, N., Petridis, A., Bolanos, N., Sagriotis, A., & Synodi-nou, M. (2003). Effect of amifostine on toxicities associated with radiochemo-therapy in patients with locally advanced non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics, 57,402-408.
23. Buentzel, J., Micke, O., Adamietz, I.A., Monnier, A., Glatzel, M., & de Vries, A. (2006). Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: A randomized placebo-controlled phase III study. International Journal of Radiation Oncology, Biology, Physics, 64,684-691.
24. Hwang, W.Y., Koh, L.P., Ng, H.J., Tan, P.H., Chuah, C.T., Fook, S.C., et al. (2004). A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem call transplantation. Bone Marrow Transplantation, 34, 51-56.
25. Jantunen, E., Kuittinen, T., & Nousiainen, T. (2002). A pilot study on feasibility and effcacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeloma patients. Leukemia and Lymphoma, 43,1961-1965.
26. Lorusso, D., Ferrandina, G., Greggi, S., Gadducci, A., Pignata, S., Tateo, S., et al. (2003). Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. Annals of Oncology, 14, 1086-1093.
27. Spencer, A., Horvath, N., Gibson, J., Prince, H.M., Herrmann, R., Bashrod, J., et al. (2005). Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation. Bone Marrow Transplantation, 35,971-977.
28. Thieblemont, C, Dumontet, C, Saad, H., Roch, N., Bouafa, F., Arnaud, P., et al. (2002). Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma. Bone Marrow Transplantation, 30, 769-775.
29. Donnelly, J.P., Bellm, L.A., Epstien, J.B., Sonis, ST., & Symonds, R.P. (2003). Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infectious Diseases, 3, 405-412.
30. Kim, J.H., Chu, F., Lakshmi, V., & Houde, R. (1985). A clinical study of benzy-damine for the treatment of radiotherapy-induced mucositis of the oropharynx. International Journal of Tissue Reactions, 7,215-218.
31. Schubert, M.M., & Newton, R.E. (1987). The use of benzydamine HCl for the management of cancer therapy-induced mucositis: preliminary report of a multicentre study. International Journal of Tissue Reactions, 9, 99-103.
32. Worthington, H.V., Clarkson, J.E., & Eden, O.B. (2004). Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews, 2, CD001973.
33. Epstein, J.B., Silverman, S., Paggiarino, D.A., Crockett, S., Schubert, M.M., Senzer, N.N., et al. (2001). Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: Results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer, 92, 875-885.
34. Stokman, M.A., Spijkervet, F.K., Burlage, F.R., & Roodenburg, J.L. (2005). Clinical effects of furbiprofen tooth patch on radiation-induced oral mucositis. A pilot study. Supportive Care in Cancer, 13,42-48.
35. Crawford, J., Tomita, D.K., Mazanet, R., Glaspy, J., & Ozer, H. (1999). Reduction of oral mucositis by flgrastim 9r-met (HUG-CFF) in patients receiving chemotherapy. Cytokines Cellular and Molecular Therapy, 5, 187-193.
36. Katano, M., Nakamura, M., Matsuo, T., Iyama, A., & Hisatsugu, T. (1995). Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis. Surgery Today, 25, 202-206.
37. McAleese, J.J., Bishop, K.M., A'Hern, R., & Henk, J.M. (2006). Randomized phase II study of GM-CSF to reduce mucositis caused by accelerated radiotherapy of laryngeal cancer. British Journal of Radiology, 79, 608-613.
38. Rossi, A., Rosati, G., Colarusso, D., & Manzione, L (2003). Subcutaneous granulocyte-macrophage colony-stimulating factor in mucositis induced by an adjuvant 5-fuorouracil plus leucovorin regimen. Oncology, 64, 353-360.
39. Cerchietti, L.C., Navigante, A.H., Lutteral, M.A., Castro, M.A., Kirchuck, R., Bonomi, M., et al. (2006). Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemo-radiotherapy in patients with head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics, 65, 1330-1337.
40. Nes, A.G., & Posso, M.B. (2005). Patients with moderate chemotherapy-induced mucositis: Pain therapy using low intensity lasers. International Nursing Review, 52, 68-72.
41. Genot, M., & Klastersky, J. (2005). Low-level laser for prevention and therapy of oral mucositis induced by chemotherapy or radiotherapy. Current Opinion in Oncology, 17, 236-240.
42. Su, C.K., Mehta, V., Ravikumar, L, Shah, R., Pinto, H., Halpern, J., et al. (2004). Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms. International Journal of Radiation Oncology, Biology, Physics, 60, 171-177.
43. Miller, M., & Kearney, N. (2001). Oral care for patients with cancer: A review of the literature. Cancer Nursing, 24, 241-254.
44. Awidi, A., Homsi, U., Kakail, R.I., Mubarak, A., Hassan, A., Kelta, M., et al. (2001). Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer. European Journal of Cancer, 37, 2010-2014.
45. Lockhart, P.B., Brennan, M.T., Kent, M.L., Packman, C.H., Norton, H.J., Fox, PC, et al. (2005). Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation. Bone Marrow Transplantation, 35,713-720.